- ICH GCP
- US Clinical Trials Registry
- Forskere
- Australia
- Multippelt myelom
Medisinske spesialister fra Australia merket som etterforskere i kliniske studier som studerer Multippelt myelom
Totalt 28 resultater
-
Alvin MilnerSett i:
- Victoria, Melbourne, Peter MacCallum Cancer Centre
Prøver:- NCT00431990 (Underetterforsker)
Betingelser: -
Andrew LimSett i:
- Victoria, Heidelberg, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Andrew SpencerSett i:
- Victoria, Melbourne, The Alfred Hospital
Prøver:- NCT05590377 (Hovedetterforsker)
Betingelser: -
Bradley AugustsonSett i:
- Western Australia, Nedlands, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
- NCT05714839 (Hovedetterforsker)
Betingelser: -
Cecily ForsythSett i:
- New South Wales, Gosford, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
David Ritchie, MBBS, PhDSett i:
- Victoria, Melbourne, Melbourne Health
Prøver:- NCT05005299 (Hovedetterforsker)
-
Edwin LeeSett i:
- Australian Capital Territory, Canberra, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Eric Wong, MBBS, PhDSett i:
- Victoria, Melbourne, Melbourne Health
Prøver:- NCT05005299 (Underetterforsker)
-
Hang QuachSett i:
- Victoria, Fitzroy, GSK Investigational Site
Prøver:- NCT04126200 (Hovedetterforsker)
- NCT04484623 (Hovedetterforsker)
- NCT05714839 (Hovedetterforsker)
Betingelser: -
Hanlon SiaSett i:
- Queensland, Benowa, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Huey-Shin Cindy LeeSett i:
- South Australia, Adelaide, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Ian IrvingSett i:
- Queensland, Brisbane, Icon Cancer Centre
- Queensland, South Brisbane, GSK Investigational Site
Prøver:- NCT04603495 (Hovedetterforsker)
- NCT04484623 (Hovedetterforsker)
-
James H McMahon, MBBS PhDSett i:
- Victoria, Melbourne, Alfred Health
Prøver:- NCT05556720 (Hovedetterforsker)
-
Jock SimpsonSett i:
- New South Wales, Port Macquarie, GSK Investigational Site
- Port Macquarie, Port Macquarie
Prøver:- NCT04332822 (Hovedetterforsker)
- NCT04484623 (Hovedetterforsker)
Betingelser: -
Keith FaySett i:
- New South Wales, Darlinghurst, GSK Investigational Site
- New South Wales, Saint Leonards, Royal North Shore Hospital
Prøver:- NCT04685616 (Hovedetterforsker)
- NCT04484623 (Hovedetterforsker)
Betingelser: -
Kenealy MelitaSett i:
- Victoria, Melbourne, Cabrini Health
Prøver:- NCT04735575 (Hovedetterforsker)
Betingelser: -
Mark HertzbergSett i:
- New South Wales, Randwick, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Melita KenealySett i:
- Victoria, Malvern, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Miles Prince, FRACPSett i:
- Victoria, Richmond, Epworth Healthcare
Prøver:- NCT04735575 (Hovedetterforsker)
Betingelser: -
Nicole Caroline Wong DooSett i:
- New South Wales, Concord, Concord Repatriation General Hospital
Prøver:- NCT05590377 (Hovedetterforsker)
Betingelser: -
Peter PresgraveSett i:
- New South Wales, Wollongong, GSK Investigational Site
- New South Wales, Wollongong, Wollongong Private Hospital
Prøver:- NCT04484623 (Hovedetterforsker)
- NCT06088654 (Hovedetterforsker)
Betingelser: -
Peter Tan, FRACPSett i:
- Western Australia, Nedlands, One Clinical Research (OCR)
Prøver:- NCT04735575 (Hovedetterforsker)
Betingelser: -
Philip CampbellSett i:
- Victoria, Geelong, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Rachel Koldej, PhDSett i:
- Victoria, Melbourne, Melbourne Health
Prøver:- NCT05005299 (Underetterforsker)
-
Ray Mun Koo, MBBSSett i:
- Victoria, Melbourne, Melbourne Health
Prøver:- NCT05005299 (Underetterforsker)
-
Simon HarrisonSett i:
- Victoria, Melbourne, Peter MacCallum Cancer Centre
Prøver:- NCT05666700 (Hovedetterforsker)
Betingelser: -
Sorab Shavaksha, MBBSSett i:
- Queensland, Buderim, Sunshine Coast Haematology and Oncology Clinic (SCHOC)
Prøver:- NCT04735575 (Hovedetterforsker)
Betingelser: -
Wojciech JanowskiSett i:
- New South Wales, Waratah, GSK Investigational Site
Prøver:- NCT04091126 (Hovedetterforsker)
Betingelser:
Kliniske studier på Multippelt myelom
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)AvsluttetMyelom, multippel | Myelom-multippelForente stater
-
Tel-Aviv Sourasky Medical CenterFullførtPlasmacellemyelom | Myelom-multippel | Myelom multippel | Myelom, plasmacelleIsrael
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthAvsluttetMyelom-multippel | Myelom, plasmacelle | MyelomatoseForente stater
-
University of ChicagoNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationAvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TilbaketrukketStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom